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Abstract
The essential histone variant H2A.Z localises to both active and silent chromatin sites. In embryonic stem cells (ESCs), H2A.Z
is also reported to co-localise with polycomb repressive complex 2 (PRC2) at developmentally silenced genes. The
mechanism of H2A.Z targeting is not clear, but a role for the PRC2 component Suz12 has been suggested. Given this
association, we wished to determine if polycomb functionally directs H2A.Z incorporation in ESCs. We demonstrate that the
PRC1 component Ring1B interacts with multiple complexes in ESCs. Moreover, we show that although the genomic
distribution of H2A.Z co-localises with PRC2, Ring1B and with the presence of CpG islands, H2A.Z still blankets polycomb
target loci in the absence of Suz12, Eed (PRC2) or Ring1B (PRC1). Therefore we conclude that H2A.Z accumulates at
developmentally silenced genes in ESCs in a polycomb independent manner.
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Introduction
Genome-wide mapping relative to cis-regulatory elements and
transcriptionally active and repressed loci has implicated histone
modifications in gene regulation. Another mechanism of chroma-
tin regulation is the replacement of core histones with histone
variants. Unlike the S-phase restricted expression of canonical
histones, histone variants are expressed throughout the cell cycle.
They have been implicated in the regulation of transcription,
DNA repair, chromosome segregation and spermatogenesis [1].
Variant histone H2A.Z is essential and has been linked to both
transcriptional activation and repression [2]. In Drosophila embryos
[3] and human CD4+ T cells [4], H2A.Z is enriched around the
transcription start site (TSS) of active genes and it is incorporated
into promoters of estrogen-receptor target genes upon their
induction by estrogen [5]. Consistent with a link to active
chromatin, TSS-proximal H2A.Z containing nucleosomes are
enriched in H3K4me3 and depleted in H3K9 methylation [4]. In
Saccharomyces cerevisiae H2A.Z is at promoters of both active and
inactive genes [6] and prevents the spreading of telomeric
heterochromatin into euchromatin [7,8].
Despite the association with transcriptional activity, Drosophila
H2A.Z (H2Av) is also involved in the establishment of centromeric
heterochromatin. It co-localises with Heterochromatin protein 1
alpha (HP1a) at pericentric heterochromatin in some mouse cells
[9,10] and it has been suggested to co-operate with HP1a to
stabilise compact chromatin [11,12].
H2A.Z/H2Av is also implicated in polycomb-mediated gene
silencing in Drosophila [11] and in mouse embryonic stem cells
(ESCs). H2A.Z occupies a similar set of silent developmental genes
as the polycomb repressive complex 2 (PRC2) component Suz12
[13]. PRC2 trimethylates histone H3 lysine 27 (H3K27me3)
through the action of the histone methyltransferases (HMTases)
EZH1/2 [14]. This creates a binding platform for recruitment of
the PRC1, which contains the E3 ligases Ring1A/B that can
monoubiquitinate histone H2AK119 (H2AK119ub1) [15]. More-
over, Ring1B can also monoubiquitinate H2A.Z at several lysine
residues in the C-terminal tail, including K120 [9]. H2A.Zub is
enriched on the inactive X chromosome of female mammalian
cells indicating a link with facultative heterochromatin [9].
PRC2 has been suggested to be necessary for H2A.Z
incorporation into silent genes in ESCs and, reciprocally, H2A.Z
knockdown was reported to impair PRC2 binding and gene
repression at polycomb-target loci [13]. This suggested some
mutual dependency between H2A.Z and polycomb.
Exchange of H2A/H2B dimers with H2A.Z/H2B is mediated
by the SWR1 ATP-dependent chromatin remodelling complexes
(Tip60-p400.com, SWR1-C and NuA4 complex) [16,17,18,19].
Tip60-p400.com is important in maintaining ESC identity and
repression of developmental genes, and the p400 ATPase subunit
is detected at most PcG target genes [20].
How H2A.Z deposition is targeted to polycomb genes in ESCs,
and whether it is dependent on PRC1 as well as PRC2, are not
known. To address these questions, we identified Ring1B-
associated proteins in ESCs and did find components of
p400.com. We show that H2A.Z co-localizes with H3K27me3,
EZH2 and Ring1B at developmentally silenced gene loci in ESCs.
However, using ESCs mutant for Suz12, Eed (PRC2) or Ring1B
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(PRC1), we show that H2A.Z enrichment at these genes is not
dependent on either PRC2 or Ring1B (PRC1). Rather we find
that H2A.Z occupancy correlates well with the presence of CpG
islands.
Results
Ring1B is Associated with known Polycomb Complexes
in ESCs
In somatic cells, proteomic analysis has identified that Ring1B is
present in several complexes including PRC1, BcoR and
E2F6.com [21,22,23,24,25], however a full analysis of Ring1B
partners has not been examined in ESCs.
We have previously shown that PRC1 components Phc2, Mel18
and Rybp are immunoprecipitated (IP’d) with Ring1B in mouse
ESCs, while PRC2 component Ezh2 did not interact [26]. To
determine the more complete Ring1B interaction network, we
IP’d endogenous Ring1B from ESC nuclear extract and identified
the associated proteins by mass spectrometry (nLC-ESI-MS/MS)
(Fig. 1A and Table S1). Amongst the associated proteins we found:
Phc1/2, Snf2h, Ring1A, Rybp, Pcgf3/6, Bmi1, Mel18 and Cbx4/
8 - all previously found to be components of, or associated with,
PRC1 [27]. Moreover, we identified Ogt whose Drosophila
homologue O-GlcNAcylate Polyhomeotic and is involved in
polycomb repression [28,29].
In somatic cells, Ring1B was also previously co-purified as a
component of the Bcl6 co-repressor complex (BcoR) [21,22] which
has a role in regulating gene expression during early ectoderm and
mesoderm differentiation [30]. We found BcoR itself and the
lysine demethylase Fbxl10 co-purifying with Ring1B. We also
identified H3K4 demethylase Kdm1a/Lsd1 that interacts with
BcoR in somatic cells [22], but we did not identify NsPC1/Pcgf1.
We further identified major components of the E2F6.com
repressive complex: E2F.6, Mga, Mbtd1, L3mbtl2/3 [31].
L3MBTL2 has recently been described in a PRC1-like complex
containing RING1A, RING1B, PCGF6 (MBLR), E2F6 and
HP1g, and is involved in repression of a different set of targets
from PRC2 [32].
Unexpectedly we also identified polypeptides for components of
the Mll2 complex; Mll2, Wdr5, Paxip1 and Kdm6a, as well as
HMG20a/b which are known to act as recruiters of the Mll
complex [33]. There were a number of other proteins identified
that were not previously known to interact with Ring1B (Fig. 1A,
Table S1 and S2).
We have previously shown that I53A mutant Ring1B is unable
to ubiquitinate H2A in vivo, but is nevertheless able to interact
with other PRC1 components and is able to, compact the
chromatin, and repress the expression, of Hox loci in ESCs [26].
nLC-ESI-MS/MS analysis of the I53A Ring1B IP revealed exactly
the same protein complexes as for wild-type (WT) Ring1B (Fig. 1A,
Table S2.) indicating that, as predicted in vitro [34], mutation of the
I53 surface residue does not interfere with the incorporation of
Ring1B into stable protein complexes.
Ring1B Interacts with Subunits of p400.com
Interestingly, we identified most subunits (Trrap, p400, Epc1,
Brd8, Dmap1, Ruvbl2, Baf53a, Mrgbp and actin) of p400.com
[19], in the Ring1B IPs from ESC nuclear extracts (Fig. 1A and
Tables S1 and S2). Benzonase nuclease treatment of the extract
prior to IP confirmed that the Ring1B/p400 interaction is not
dependent on nucleic acids (Table S3). Dmap1 had previously
been found to interact with Bmi1 [35] and we show the Dmap1
interaction with Ring1B by immunoblot in WT and Ring1B-
rescued cell lines (Fig. 1B). Dmap1 also co-fractionates with
Ring1B in high molecular weight fractions in a sucrose-sizing
gradient (Fig. S1). Ring1B fractionates with a broad profile
supporting our finding that it is a constituent of multiple
complexes in ESCs.
The human p400.com has previously been purified without
the histone acetyltransferase (HAT) subunit Tip60/Kat5 associ-
ated [36] and we did not detect Tip60 in our Ring1B IPs.
Formally, we cannot exclude that Tip60 is present as it has a
similar size to the IgG heavy chain, which was omitted from the
M/S analysis. We did however identify the HATs p300 and
CBP, known to interact with p400.com in HeLa cells [36].
Nevertheless, we were not able to detect Ring1B by immuno-
blot or nLC-ESI-MS/MS in an IP for p400 (Figs. 1C, 1D and
Table S4). Therefore, we suggest that p400 does not interact
directly with Ring1B, but can associate with other components
of Ring1B-containing complexes.
To further address the potential interaction of Ring1B with
components of p400 and MLL2 complexes we performed size
exclusion chromatography. Nuclear extract from WT ESCs was
treated with RNase A and Benzonase nuclease, and separated on a
Superose 6 column (Fig 1E). As a control we probed for PRC2
components Ezh2 and Suz12 and show that they co-fractionates in
a broad peak (fractions 16–32). Ring1B shows a broad elution
profile (fractions 16–30), consistent with sucrose gradient sedi-
mentation data (Fig. S1), indicating participation in multiple
PRC1- like complexes (Fig 1E). Rybp display a low molecular peak
(fraction 28–34) and co-elutes with Ring1B in fractions 20–22. We
observe that p400 and Dmap1 co-fractionates in high molecular
weight complexes (440 kDa–2 MDa, fractions 16–28). The MLL
component Menin is also found in fractions with molecular size
from 440 kDa and 2 MDa, and peaks with Mll2 in fractions 18–
20. Ring1B overlaps with p400, Dmap1 and Mll2 over several
fractions, however, the main peaks of p400.com and Mll2 is at a
larger molecular weight. We therefore suggest that Ring1B is not a
stable component of these two complexes.
H2A.Z Occupies Polycomb Targets in Ring1B Deficient
ESCs
The presence of p400.com components in our Ring1B IPs
prompted us to re-examine the relationship between H2A.Z
occupancy and polycomb. A previous study had shown that
H2A.Z is enriched at silenced developmental gene loci in ESCs
that are also occupied by the PRC2 protein Suz12 [13].
Furthermore, H2A.Z was perturbed at these sites in Suz12
deficient ESCs, but the influence of PRC1 was not examined.
Therefore, we sought to determine whether loss of Ring1B (PRC1)
disrupts H2A.Z deposition at polycomb targets in ESCs.
We show that the H2A.Z antibody detect global levels of H2A.Z
in WT ESC and calf thymus histones but did not recognize
recombinant human H2A by immunoblot (Fig. S2A). Further we
observed no change in the global levels of H2A.Z In Ring1B2/2
ESCs compared to WT cells (Fig. 2A) [37]. Chromatin
immunoprecipitation (ChIP) and real-time PCR (q-PCR) showed
that, though occupancy by H2A.Z is marginally reduced at the
promoter of Hoxd10 in the absence of Ring1B, it is unaffected at
Hoxb13 and Gata4, and even increased, at the promoters of Hoxb1
and Cdx2 (Fig. 2B). The pluripotency genes Nanog and Pou5f1 have
only low levels of H2A.Z, which is above the IgG control
background, and that is not affected in Ring1B mutant cells.
Immunoblot of nuclear extract and q-PCR of Ring1B ChIP at the
promoters of Hoxb1, Hoxd1 and Hoxd10 confirmed that Ring1B is
absent in Ring1B2/2 ESCs (Fig. S3A and B).
H2A.Z and Polycomb
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EZH2 and H3K27me3 Coat Polycomb Target Loci in the
Absence of Ring1B
We have previously shown that blanketing of H3K27me3 across
the Hoxb and d loci is not grossly affected in the absence of
Ring1B [26]. This is consistent, at least at these loci, with a model
in which PRC1 acts downstream of PRC2, and PRC2 recruitment
and maintenance does not solely depend on Ring1B-containing
PRC1 activity [15,38,39].
To examine this more widely and to directly show binding of
EZH2 in the absence of Ring1B, we performed ChIP on chip
using a custom tiling array that covers many murine polycomb
target loci, pluripotency genes and other non-polycomb target loci.
Consistent with previous studies [40,41,42,43], EZH2 and
H3K27me3 specifically occupy all four Hox loci as well as the
polycomb targets Nkx2-9, Cdx2 and Pax6 in WT ESCs. Ring1B
occupies the same subset of developmental genes (Figs. 3 and 4)
[42,44,45]. There is low polycomb enrichment over the highly
transcribed Nanog and b-Actin [41] genes, but none at the silent
Magea3, b-globin and surrounding olfactory receptor gene clusters
that are not polycomb targets (Fig. 4) [46].
In the absence of Ring1B (Ring1B2/2) polycomb target genes
are upregulated (Fig. 2C) [26,44,45,47]. Nkx2-9, Cdx2 and Pax6
remain coated by H3K27me3 and EZH2 (Figs. 4) [26,37,45],
consistent with Ring1B functioning downstream of PRC2.
H3K27me3 and EZH2 also blanket the Hox loci in Ring1B2/2
ESCs, albeit we observe some reduction in levels at specific
regions: between Hoxa1 and 2, in the Hoxa3 intronic region,
between Hoxb9 and b13, and at the Hoxd4 promoter (Figs. 3).
H2A.Z is Enriched at Promoters of Both Active and Silent
Genes in the Absence of Ring1B
By ChIP on chip in WT ESCs we found that H2AZ occupancy
at all four paralogous Hox loci and at the other polycomb targets
examined overlaps with the distribution of H3K27me3, EZH2
and Ring1B. Moreover, H2A.Z remains at these regions in the
absence of Ring1B (Figs. 3 and 4).
Consistent with our q-PCR data (Fig. 2B), but contrary to the
study of Creyghton et al. [13], we also observe low, but significant,
levels of H2A.Z by ChIP on chip at the promoters of the
transcriptionally active Nanog and Pou5f1 (Figs. 2B, C and 4). This
discrepancy may be due to the better efficiency of the batch of
H2A.Z antibody that we have used here (Fig. S2B, compare
batches 170693 vs. 737918). H2A.Z also peaks around the TSS of
highly transcribed genes (Skap2, Hibadh, Atp5g1 and Snf8) that flank
Hox loci (Figs. 3).
The germline specific gene Tex19.1 is also expressed in ESCs
[48] and its promoter and 59end are enriched with H2A.Z (Fig. 4).
There are low levels of EZH2 and H3K27me3 at the Tex19.1
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promoter and low levels of Ring1B both at the promoter, 5 and 39
ends of the gene. Unlike most polycomb targets, levels of EZH2
and H3K27me3 are reduced at the Tex19.1 promoter in the
absence of Ring1B, suggesting that there is a dependency of PRC2
on Ring1B activity at this locus. Interestingly, Tex19.1 expression
is upregulated in Ring1B2/2 ESCs (Fig. 2C) and this correlates
with loss of H2A.Z around the TSS.
The silent b-globin genes and olfactory receptor gene clusters
have no detectable H2A.Z, EZH2 or Ring1B at these loci (Fig. 4).
H2A.Z Deposition in ESCs is not Dependent on PRC2
Function
The general blanketing of H2A.Z at polycomb-regulated loci,
even in Ring1B mutant cells, prompted us to re-examine the
H2A.Z levels in cells lacking PRC2 function. Mutation of Eed leads
to global loss of H3K27me3 in ESCs (Fig. 5A) [26,41,49,50]. As
observed for Ring1B2/2 (Fig. 2A), immunoblotting of Eed2/2
ESCs did not reveal a global loss of H2A.Z (Fig. 5B) [37].
Moreover, we observed no difference in H2A.Z levels by ChIP
and q-PCR at the promoters of polycomb target loci (Hoxb1,
Hoxb13, Gata4), or the promoters of the active Pou5f1 and Nanog
between wild-type and Eed2/2 cells (Fig. 5C). This was seen with
different batches of H2A.Z antibody and by two independent
observers R.S.I and R.E (Fig. 5C; 2n batch 170693 and 1n batch
737918; see also Fig. S2B).
Our finding that H2A.Z levels were unchanged in Eed2/2
cells led us to investigate H2A.Z enrichment in Suz122/2 cells,
used in the Creyghton et al [13]. Consistent with previous
observations, global levels of H3K27me3 is lost in Suz122/2
ESCs (Fig. 5D) [51] and the global H2A.Z levels are unchanged
(Fig. 5E). And as observed in Eed2/2 cells, we found no change
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in H2A.Z levels by ChIP and q-PCR at promoters of Hoxb1,
Pou5f1 and Nanog between wild-type ESCs (Fig. 5F). We did
observe a slight decrease on the promoters of polycomb target
loci (Hoxb13, Hoxd10, Gata4 and Cdx2). However, we did not
observe a drop to background levels as described for H2A.Z
enrichment at the promoter of Hoxb13 and other polycomb
targets by Creyghton et al [13].
To examine this more widely and to directly show binding of
H2A.Z in the absence of PRC2, we did ChIP on chip on our
custom tiling array (Figs. 6 and 7). H2A.Z ChIP on chip shows the
same enrichment in both WT (Ring1B+/+ and Eed+/+) ESCs, and
we found that H2AZ occupancy at all four paralogous Hox loci
and polycomb targets (Figs. 3, 4, 6 and 7). Moreover, H2A.Z
blankets these regions in the absence of Eed or Suz12 (Figs. 6 and
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7), and this was also true for the non-normalized datasets (data not
shown). We did not observe a difference in H2A.Z enrichment
over the active genes Actb and Nanog.
As we observed a decrease at promoters of Hoxb13, Hoxd10,
Gata4 and Cdx2 by q-PCR in Suz122/2 cells (Fig. 5F), we
performed pair wise scatter plot analysis of the different H2A.Z
ChIP on chip datasets over +/2 1 kb of each arrayed TSS. The
calculated correlation scores show that there is no difference
between the two WT and three PRC mutant cells (Fig. S5).
The discrepancy of these data to the findings of Creyghton et al
[13], led us to compare the distribution of H2A.Z, H3K27me3
and EZH2 across the genomic regions on our tiling array. There is
an extensive overlap between H2A.Z, EZH2 and Ring1B across
promoters (TSS +/2 0.5 kb) - H2A.Z bound TSSs overlaps 91%
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with EZH2 and 86% with Ring1B (Fig. 8A). However, we do not
detect H2A.Z at approximately 30% of EZH2 and Ring1B bound
TSS (Fig. 8A).
H2A.Z Localises to CpG Islands
H2A.Z occupancy and DNA methylation are inversely
correlated in plants and human B-cells [52,53]. Polycomb target
genes are generally associated with CpG islands (CGIs) that are, in
the majority, unmethylated in ESCs [54]. CGIs have also been
suggested to be important for recruiting polycomb complexes
[42,55,56]. Indeed, we found that across the entire tiling array
H2A.Z enrichment is higher at CGIs, than at TSS, exons, introns,
or transcription end sites (TES) (Fig. 8B). Similarly, H3K27me3,
EZH2 and Ring1B are most highly enriched at CGIs, followed by
TSS and exons (Fig. 8C). Interestingly, this trend was not seen at
the Hox loci. Here H3K27me3, EZH2, Ring1B and H2A.Z were
highly enriched over all classes of sequence examined (Figs. 8B and
8C). We also noted that H2A.Z is absent from the CpG-rich
promoter of Magea3 that is regulated by Dnmt-mediated DNA
methylation in ESCs (Fig. 4) [54].
We further compared the occupancy of EZH2 in WT versus
Ring1B2/2 cells, and found it was still present, though reduced, at
CGIs, exonic and intronic sequences across the entire tiling array
(Figure S4). H2A.Z enrichment also showed a smaller, but
significant, decline at the same classes as EZH2 in Ring1B2/2
cells (CGIs, exonic and intronic). There was not a significant
decrease of EZH2 and H2A.Z over TSS and TES on all arrayed
genes (Figure S4C and F). Together, our finding demonstrate that
H2A.Z is highly enriched at CGIs in ESCs and that in the absence
of Ring1B, H2A.Z occupancy is reduced to a lesser extent than
EZH2 and still blankets polycomb target genes.
Discussion
Ring1B Interacts with Multiple Protein Complexes in ESCs
We have shown that Ring1B is part of several PRC1-like
complexes in ESCs (PRC1 BCOR, PRC1L3, PRC1L4 and
E2F6.com [21,22,23,24,25,32]) and it will be important to dissect
the respective functions of these different complexes at different
target loci in ESCs.
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We identified several subunits of the p400.com interacting with
Ring1B, but we did not identify Ring1B or Tip60 in mass
spectrometry analysis of the p400 IP. Biotin-tagging of Tip60 to
map interactions in ESCs has previously identified the p400.com,
but Ring1B was not co-purified [57]. We therefore suggest that
p400 interact indirectly with Ring1B and that this may be through
Dmap1 who has previously been found to interact with Bmi1
known to form heterodimer with Ring1B [35].
We identified Ogt in our Ring1B IP from ESCs nuclear extracts
and this interaction was not affected by mutation of I53A mutant
version of Ring1B that abolishes the ubiquitnation catalytic
activity. Drosophila Ogt O-GlcNAcylates Polyhomeotic and is
involved in polycomb repression [28]. Ogt has also been pulled
down with Oct4 in ESCs, together with Ring1B, Phc1, Trrap, and
p400 [58]. Furthermore, the Ph homolog Phc3 is O-GlcNAcylated
in ESCs [59]. The role of O-GlcNAcylation mediated interactions
needs to be explored further.
The transcription regulator Max is part of E2F6.com [31] and
has recently been shown to interact with Ring1B, p400, Dmap1,
Brd8, Tip60 and Trrap in ESCs [57]. This supports our finding
that there may be a link between Ring1B, E2F6.com and
p400.com. The Drosophila p400 homolog (Domino) interacts
genetically with E2F and, together with MBT proteins, represses
E2F target genes [60]. Moreover, Domino also represses Hox genes
through a genetic interaction with PcG and TrxG [61].
We were surprised to find members of Mll2 complex in our
Ring1B IP. However, this is not the first time TrxG proteins are
identified together with PRC components. Ring1B has been
previously been found in the MLL1-Wdr5 complex from Hela S3
cells [62] and in Drosophila, biotinylated Pc pulled down Ring1 and
many Trx related proteins [63].
We used size exclusion chromatography of WT ESC nuclear
extract to compare Ring1B elution profiles with IP’d components
of p400 and MLL2 complexes (Fig 1E). Ring1B elutes with an
apparent molecular weight of ,200 kDa ,1 MDa. Human
PRC1 has an estimated size of ,500 kDa [25], and our gel
filtration chromatography confirms our IP data that Ring1B
participate in multiple PRC1- like complexes. Although there is
some overlap of Ring1B with p400 and MLL2 complex
components, these complexes elute with a higher molecular
weight (669 kDa–2 MDa), which indicates that Ring1B is not a
stable component of these two complexes (Fig. 1E).
The identification of these novel interacting proteins of Ring1B
may increase our understanding of its functions in multiple protein
complexes in ESCs, and further studies are needed.
Specific Sites of Ring1B-mediated PRC2 Recruitment
We saw that H3K27me3 and EZH2 mostly remained coating
polycomb target genes in Ring1B2/2 ESCs (Figs. 3 and 4).
However, we did observe a general decrease of EZH2 across the
Hox loci (Fig. S4A) and at some other specific sites. We conclude
that the majority of EZH2 targeting is independent of Ring1B, but
may be stabilized in the presence of PRC1-like complexes.
H2A.Z Occupancy is not Dependent on Polycomb
Complexes
Consistent with a previous report, we found that H2A.Z and
polycomb (Ring1B, EZH2 and H3K27me3) co-occupy a common
set of repressed developmental genes in ESCs (Figs. 3 and 4) [13].
This also compares well with another ChIP study showing p400
enrichment at the Hoxa locus, Pax6 and Nkx2-9 in ESCs [20]. We
saw some enrichment of H2A.Z at the active Actb and Nanog genes,
but not at the b-globin locus (Fig. 4) [20]. Moreover, H2A.Z is
highly enriched at CGIs, as has also been observed for
H3K27me3, EZH2 and Ring1B (Figs. 6B and C) [42,55].
Contrary to the study of Creyghton et al [13], we conclude that
the major targeting mechanism of H2A.Z to these genes is not
dependent on either H3K27me3 (Eed2/2), a functional PRC2
complex (Eed2/2), or a functional PRC1 complex (Ring1B2/2).
H2A.Z is still enriched at polycomb target genes in these Ring1B
or PRC2 mutant ESCs and we only observed subtle changes in
H2A.Z abundance by qRT-PCR and array analysis in mutant
cells (Figs. 2B, 3, 4, 5B, and S4A-F). We also performed H2A.Z
ChIP in the Suz122/2 cells that were used in the Creyghton et al.
[13] and did not observe the same dramatic drop to background
levels of H2A.Z enrichment at developmental gene promoter
regions and found that H2A.Z still blankets polycomb targets
across arrayed regions (Figs. 5F, 7, 8 and S5). Therefore we think it
is more likely that the explanation of discrepancy lies in differences
in the efficiencies of the H2A.Z antibodies used (Fig S2B).
RNAi knockdown of p400 and Tip60, but not H2A.Z, affects
ESC pluripotency, suggesting that the functional role of the p400
complex in pluripotency is not through H2A.Z incorporation [20].
Moreover, Ring1B knockdown resulted in a flattened colony
morphology that was not seen for H2A.Z RNAi [20]. If polycomb
complexes were orchestrating H2A.Z incorporation we would
expect to find H2A.Z on all polycomb bound TSS. However we
find a sizeable proportion of Ring1B and EZH2 enriched TSS that
is not enriched for H2A.Z (Fig. 8A). Unmethylated CGIs have
been suggested to contribute to polycomb recruitment in ESCs
[55]. Indeed, we find that H2A.Z is most enriched at CGIs, and it
is also located at transcription start sites (TSS) and exons. We
conclude that it will be important to dissect the role of CGIs in
recruitment of H2A.Z in ESCs.
Materials and Methods
Tissue Culture
The ESC line OS25 was cultured as previously described [26].
Feeder dependent ESC lines; Clone36 (Ring1B+/+), Ring1B2/2
[47], Ring1B rescued cell lines [26], Suz122/2 (SBE8) [51], Eed+/+
clone 2.21 and Eed mutant (17Rn5-3354SB) (Eed2/2 B1.3) [49]
were grown on mitomycin C-treated primary embryonic fibro-
blasts (PEFs) derived from E12.5 mouse embryos, in DMEM
(Invitrogen) supplemented with 15% foetal calf serum (FCS,
Hyclone), 1,000 units/ml LIF, non-essential amino acids, sodium
pyruvate, 2-mercaptoethanol, L-glutamine, and Penicillin/Strep-
tomycin. ESCs were trypsinized and the PEFs allowed re-
attaching to the tissue culture plastic for 2630 minutes in LIF-
containing medium, before preparation of chromatin, and nuclear
extracts from ESCs.
Nuclear Extract Preparation and Immunoprecipitation
Nuclear extract was prepared from 2246108 ESCs according
to [64] with the following modifications: After precipitation with
1/10th volume of 4 M (NH4)2SO4 and mixing for 20 min, the
lysate was cleared by centrifugation at 45,000 rpm (235,0006g) in
a TL-100 ultracentrifuge (Beckman, Mountain View, CA). The
supernatant was dialysed against 3 changes of Buffer C (25 mM
HEPES pH 7.6, 150 mM NaCl, 12.5 mM MgCl2, 0.1 mM
EDTA, 10% v/v glycerol, 1 mM DTT and freshly added
complete protease inhibitors) and flash frozen in liquid nitrogen.
Protein concentrations were quantified by Bradford (Bio-Rad) and
a total of 400 mg nuclear extract were incubated with 4 mg mouse
or rabbit IgG (Santa Cruz, sc-2025 and sc-2027), anti-Ring1B
(MBL, D139-3), or anti-p400 (A300-541A-1 Bethyl Laboratories,
Inc.) and immunoprecipitated with 20 ml Protein G Sepharose
H2A.Z and Polycomb
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(GE Healthcare) for 2 h at 4uC. After three washes with BC300
(25 mM HEPES pH 7.6, 300 mM NaCl, 1 mM MgCl2, 0.5 mM
EGTA, 0.1 mM EDTA, 10% v/v glycerol, 1 mM DTT, 0.2 mM
PMSF and complete protease inhibitors containing 0.05% v/v
NP40) for 10 min each, and once with BC100 (0.05% v/v NP40),
the bound proteins were boiled in SDS sample buffer and resolved
on Novex Tris-Glycine 4–20% gels (Invitrogen). Gels were stained
with Colloidal Blue Staining Kit (Invitrogen). Bands from Ring1B
IPs and IgG control were cut for mass spectrometry analysis.
Alternatively, the IPd materials were transferred to a HybondTM-P
membrane (GE Healthcare) for immunoblotting with anti-Ring1B
and anti-p400 (Table S6).
nLC-ESI MS/MS Analysis
In-gel tryptic digestion was performed as previously described
[65]. The peptides were then separated using an UltiMate
nanoLC (LC Packings, Amsterdam) equipped with a PepMap
C18 trap & column, using a gradient of increasing acetonitrile
concentration, containing 0.1 % formic acid (5–35% acetonitrile
in 180 min respectively, 35–50% in a further 30 min, followed by
95% acetonitrile to clean the column). The eluent was sprayed into
a Q-Star XL tandem mass spectrometer (ABSciex, Foster City,
CA) and analysed in Information Dependent Acquisition (IDA)
mode, performing 1 sec of MS followed by 3 sec MSMS analyses
of the 2 most intense peaks seen by MS. These masses are then
excluded from analysis for the next 60 sec. MS/MS data for
doubly and triply charged precursor ions was converted to
centroid data, without smoothing, using the Analyst QS1.1
mascot.dll data import filter with default settings. The MS/MS
data file generated was analysed using the Mascot 2.1 search
engine (Matrix Science, London, UK) against UniProt April 2009
(7966092 sequences) or NCBInr March 2010 (10530540 sequenc-
es) databases (Taxonomy, Mus musculus). The data was searched
with tolerances of 0.2 Da for the precursor and fragment ions,
trypsin as the cleavage enzyme, one missed cleavage, carbamido-
methyl modification of cysteines as a fixed modification and
methionine oxidation selected as a variable modification. More-
over, the Mascot hits were considered valid with a protein score
.50, except for known members of the PRC1 complex. Peptides
identified in control IgG lane and specific IP lane were discarded.
All proteins were checked against the UniProtKB database
(uniprot.org). IgG heavy and light chains were omitted from the
analysis, and therefore proteins migrating with a similar molecular
size could not be identified.
Size Exclusion Chromatography
For Ring1B complex analysis a Superose 6 (10/300 GL, GE
healthcare) was calibrated with standards MW-GF-1000 (Sigma)
in BC200 buffer. One mg of WT E14 ESC nuclear extract was
incubated 5 minutes at room temperature with 10 mg RNaseA
(Roche) and 10 mg Benzonase (Novagen) and passed through a
0.22 mm filter before it was loaded on the Superose 6 column. The
column was run isocratically in BC200 buffer for 1.4 column
volumes and 0.5 ml fractions were collected. Every other fraction
were TCA precipitated, 50% of the fraction was separated on a 4-
15% SDS-PAA gel (TGX, BioRad) and immunoblotted. The
same blot was reprobed and stripped with Restore Western Blot
stripping buffer using anti-Ring1B, anti-Rybp, anti-EZH2, anti-
Suz12, anti-Menin, anti-MLL2, anti-Dmap1, and anti-p400
antibodies (Table S6). Two biological replicates were analysed.
Sucrose Gradient
A sucrose gradient experiment was performed as previously
described [66] with the following modifications: 10-50% (w/v)
sucrose gradients were prepared in BC100 buffer (25 mM
HEPES/KOH (pH 7.3), 100 mM NaCl, 1 mM MgCl2, 0.5 mM
EGTA, 0.1 mM EDTA, 10% glycerol (v/v), 1 mM DTT, and
0.2 mM PMSF). The gradient was prepared using a Gradient
Station model 153 (BioComp) set at 1 min: 50 sec/80.0 degrees/
21 rpm. A 500 mL sample containing 1.5 mg WT ESC nuclear
extract or 30 mg of individual standards (Sigma, MW-GF-1000)
was loaded on top of the gradient. Gradients were left for 30 min
at 4uC then spun in a SW41 rotor (Beckman) at 41 000 rpm for
28 h at 4uC. 0.5 mL fractions were collected and analyzed by 10%
SDS-PAGE.
Acid Extraction of Histones
Histones were extracted as described in [26]. Recombinant
human H2A was expressed and purified from Escherichia coli
BL21(DE3)pLysS as previously described [67,68], and Calf
Thymus histones (H 9250) were purchased from Sigma. Histones
were separated on a SDS-15% or 18% polyacrylamide gel and
transferred to a HybondTM-P membrane (GE Healthcare).
Membranes were probed with anti-H3, anti-H3K27me3, anti-
H2A and anti-H2A.Z (Abcam, batch 170693 and 726779).
Chromatin Immunoprecipitation
Cells were cross-linked in 1% formaldehyde at room temper-
ature for 10 min and ChIP was performed as described in [45].
Antibodies used were; Ring1B (MBL, D139-3), EZH2 (Millipore
07-689) and H2A.Z (ab4174; Abcam, batches 170693, 726779
and 737918) (Table S6). The H2A.Z antibody was raised against
C-SLIGKKGQQKT, corresponding to amino acids 116-126 of
Human H2A.Z and does not detect monoubiquitinated H2A.Z
[9]. ChIP was performed overnight (o/n) with 3 mg H2A.Z
antibody and 90 mg chromatin. For polycomb ChIPs; 10 mg
Ring1B or EZH2 antibody was incubated with 450 mg chromatin
o/n. ChIP and input chromatin was decrosslinked at 65uC for 6 h,
then treated with RNase A (Roche) at 37uC for 1 h, then with
Proteinase K (Genaxxon) at 55uC for 2 h. DNAs were purified
using the QIAquick PCR purification kit (Qiagen). Real-time PCR
analysis was carried on the LightCycler 480 System using SYBR
Green Master mix (Roche) and oligos that are described in Table
S5. The real-time thermal cycler was programmed as follows:
5 min Hotstart; 44 PCR cycles (95uC for 10 sec, 55uC for 25 sec,
72uC for 10 sec). Native ChIP for H3K27me3 is described in [26].
Microarray Amplification, Labelling, Design and Analysis
In total 10 ng of input and ChIP DNA was amplified using the
WGA2 whole genome amplification kit according to manufactur-
er’s instructions (Sigma). Amplified material was labelled with Cy3
or Cy5 using random priming with dye-labelled random hexamers
according to the NimbleGen ChIP-chip protocol (Roche). In total,
2 biological replicates with dye swaps were hybridized for 20 h
and washed according to manufacturer’s protocol.
A custom 3x720K mouse tiling array (NimbleGen, Roche)
containing 179,493 unique probes from the genomic regions, with
each probe represented by 4 replicates was used. Mean and
median probe spacing is 45 bases. Arrays were scanned on a
NimbleGen MS 200 Microarray scanner (Roche) using a laser
power of 100% and 2 mm resolution and TIFF images analysed
using MS 200 Data Collection software to quantitate raw signal
intensities. The mean signal of the replicates was used for data
analysis. The data was analysed using the LIMMA package and
Bioconductor/R (version 2.10.1) (r-project.org) following Protocol
43 (www.epigenesys.eu) for Lowess normalisation [69].
For distribution analysis of Ring1B, EZH2, RNAPII and
H2AZ, microarray probes were binned according to ENSEMBL
H2A.Z and Polycomb
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gene annotation (build mm9) as either TSS associated (TSS +/
2 250 bp), exonic, intronic or associated with the transcription
end sites (TES; +/2 250 bp). Probes mapping to CpG islands
(CGIs) was also included in the analysis. Significance values
were calculated where applicable using a two-sided Wilcoxon
Rank test.
To identify regions of significant ChIP enrichment we applied
the upperBoundNull function from the bioconductor Ringo
package to each set of normalised microarray data. The threshold
value was used to identify significantly enriched probes for each
ChIP on chip dataset. TSSs (1 kb centred on the TSS) with a
minimum of 4 significant probes were considered bound and these
were cross-compared between the ChIP-chip datasets as expressed
in three-way Venn diagrams.
H2AZ distribution was compared between each cell line by
generating pair wise scatter plots depicting the mean log2 ChIP/
input ratios for all probes located +/21 kb of each arrayed TSS.
Pearson’s product-moment correlation scores for each comparison
were calculated using the ‘cor’ function in R.
All datasets are accessible from the NCBI Gene Expression
Omnibus (ncbi.nlm.nih.gov/geo/) through GEO Series accession
number GPL13276.
Expression Analysis
RNA was extracted from Ring1B+/+ and Ring1B2/2 ESCs using
Trizol reagent (Invitrogen). The quality of the RNA was assayed
using Bioanalyzer (Agilent). Four biological replicates were
amplified using Illumina TotalPrep RNA Amplification Kit and
200 ng labelled RNA was hybridized to MouseWG-6 v2.0
Expression BeadChips according to manufacturers protocol
(Illumina). Average bead signal normalised were normalised for
four datasets.
Supporting Information
Figure S1 Size fractionation of Ring1B complexes. Size
fractionation of nuclear extract from wild type OS25 ESCs by
sucrose gradient sedimentation analysis (10–50%). Fractions were
analyzed by immunoblot for Ring1B and Dmap1. Arrows indicate
fractions where protein markers with indicated molecular masses
peaked.
(EPS)
Figure S2 Characterization of the H2A.Z antibody. A)
Specificity of H2A and H2A.Z antibodies. Upper panel shows
global histones from WT ESCs (2.5 mg), calf thymus histones
(2.5 mg) and recombinant human histone H2A (500 ng and 1 mg)
were separated by 18% SDS-PAGE and immunoblotted with anti-
H2A and anti-H2A.Z (batch #726779) antibodies. Coomassie
staining of the respective blots are shown in the lower panel.
Asterisks indicate degraded H2A. B) qRT-PCR analysis at the
promoters of Hoxb13, Hoxb10 and Pou5f1 in WT ESCs after ChIP
for three different batches of anti-H2A.Z, H3K4me3 antibodies
and IgG. Enrichment is shown as mean % input bound 6 SD.
(EPS)
Figure S3 Control of Ring1B mutant ESCs. A) Forty
micrograms of cytoplasmic- (CE) and nuclear- (NE) extract from
WT and Ring1B2/2 ESCs were separated by 4–15% SDS-PAGE
and immunoblotted with anti-tubulin, anti-HP1a and anti-
Ring1B. B) ChIP for control IgG or Ring1B at the promoters of
Hoxb1, Hoxd1 and Hoxd10, assayed by qRT-PCR, in WT (grey) or
Ring1B2/2 (black) ES cell lines. Enrichment is shown as mean %
input bound 6 SD over three technical replicates. Control IgG is
shown in white bars with grey or black borders 6 SD.
(EPS)
Figure S4 H2AZ and EZH2 are similarly distributed
within all arrayed regions in WT vs. Ring1B ESCs
(Related to Figs. 3 and 4). Box plots showing the (A) log2
ChIP/Input distribution of EZH2 and H2A.Z over all probes (All)
in WT versus Ring1B2/2 ESCs. B) as described in A) over
transcriptional start sites (TSS). C) as described in A) over CpG
islands (CGI). D) as described in A) over exons. E) as described in
A) over introns. F) as described in A) over transcription end sites
(TES).
(EPS)
Figure S5 H2A.Z distribution comparisons by pair wise
scatter plots. Scatter plots representing mean log2 H2A.Z
ChIP/input for all probes located +/21 kb of each arrayed TSS
in two WT ESCs versus Ring1B2/2, Eed2/2 and Suz122/2 ESCs.
Pearson correlations are shown in upper right panels.
(EPS)
Table S1 Polypeptides associated with Ring1B (Relates to Fig. 1).
(PDF)
Table S2 Polypeptides associated with Ring1BI53A (Relates to
Fig. 1).
(PDF)
Table S3 Polypeptides associated with Ring1B in presence of
50 U Benzonase (Relates to Fig. 1).
(PDF)
Table S4 Polypeptides associated with p400 (Relates to Fig. 1).
(PDF)
Table S5 Primers for ChIP analysis (Relates to Figs. 2 and 5).
(PDF)
Table S6 Antibodies used for this study.
(DOC)
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